Bio-Rad Laboratories Financials

$389.98

$0.00 (0.00%)

As on 20-Nov-2026 09:30EST

Market cap

info icon

$10,488 Mln

Revenue (TTM)

info icon

$2,593 Mln

P/E Ratio

info icon

10.4

P/B Ratio

info icon

1.4

Div. Yield

info icon

0 %

Income Statement ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Operating Revenue
2,592.70
2,583.20
2,566.50
2,671.26
2,802.25
2,922.55
Cost of Revenue
1,263.70
1,239.60
1,187.60
1,244.32
1,234.92
1,284.45
Gross Profit
1,329.00
1,343.60
1,378.90
1,426.95
1,567.33
1,638.10
Operating Expenses
1,209.10
1,077.50
1,109.90
1,089.10
1,084.71
1,137.76
Operating Profit (EBIT)
118.90
270.50
269.00
337.80
482.62
500.34
Other Income
--
--
--
--
44.78
24.02
Profit before Tax
1,320.20
995.50
-2,342.50
-850.10
-4,704.27
5,449.06
Provision for Tax
297.30
235.60
-498.30
-212.78
-1,076.74
1,194.80
Profit after Tax (Net Income)
1,022.90
759.90
-1,844.20
-637.32
-3,627.54
4,254.26
Minority Interest
--
--
--
--
--
--
Consolidated Profit
--
--
--
--
-3,627.54
4,245.90

Liabilities ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Shareholder's Funds
7,603.00
7,453.60
6,569.30
8,741.20
9,615.25
13,685.24
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
2,211.00
2,605.90
2,327.00
3,035.10
3,317.71
3,433.22
Current Liabilities
969.10
517.00
467.80
522.80
568.71
680.94
Total Liabilities
11,752.20
10,576.50
9,364.10
12,299.10
13,501.67
17,799.39

Assets ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Non-Current Assets
7,704.50
7,670.30
6,333.80
9,250.80
10,343.64
15,808.83
Current Assets
3,078.60
2,906.20
3,030.30
3,048.30
3,157.98
1,990.48
Total Assets
11,752.20
10,576.50
9,364.10
12,299.10
13,501.67
17,799.39
Total Debt*
1,363.40
1,531.00
1,374.70
1,405.50
1,388.10
223.38
Net Current Assets
2,109.50
2,389.20
2,562.50
2,525.53
2,589.27
1,308.15

Cashflow ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Cash From Operating Activities
--
532.20
455.20
374.94
194.45
669.46
Cash Flow from Investing Activities
--
-189.70
-160.20
20.21
-1,207.59
-797.38
Cash from Financing Activities
--
-283.20
-218.80
-425.65
973.58
-55.43
Net Cash Inflow / Outflow
--
--
--
--
-39.57
-195.98

Financials Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Adjusted EPS ($) info
37.97
28.13
-65.87
-22.12
-121.76
142.18
Cash EPS ($) info
--
34.26
-60.46
-17.11
-117.15
146.65
Adjusted Book Value ($) info
--
275.94
234.64
303.36
322.75
457.36
Dividend per Share ($) info
--
--
--
--
--
--
Cash Flow per Share ($) info
--
19.70
16.26
13.01
6.53
22.37
Free Cash Flow per Share ($) info
--
13.87
9.51
7.57
2.70
17.90

Profitability Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
ROCE (%) info
--
8.98
-20.39
-6.03
-29.12
35.43
ROE (%) info
14.15
10.84
-24.09
-6.94
-31.14
36.11
ROA (%) info
9.31
7.62
-17.03
-4.94
-23.18
27.65
EBIT Margin (%) info
52.80
40.43
-89.37
-29.97
-166.51
186.50
Net Margin (%) info
39.45
29.42
-71.86
-23.86
-127.41
144.38
Cash Profit Margin (%) info
--
--
--
--
--
--

Growth Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Revenue Growth (%) info
1.38
0.01
-0.04
-0.05
-0.04
0.15
EBIT Growth (%) info
272.53
145.54
-186.45
82.84
-185.61
10.34
Net Profit Growth (%) info
251.34
141.20
-189.37
82.43
-185.27
11.54
EPS Growth (%) info
256.24
1.43
-1.98
0.82
-1.86
0.12
Book Value Growth (%) info
12.77
--
--
--
--
--

Valuation Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Price / Earnings info
10.36
--
-4.94
-14.50
-3.32
5.08
Price / Book Value info
1.38
--
1.39
1.06
1.25
1.58
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
6.36
--
-4.12
-13.80
-2.57
3.76
Close Price ($) info
365.08
--
325.60
320.65
404.66
722.91
High Price ($) info
365.08
--
352.91
467.95
735.00
818.60
Low Price ($) info
244.54
--
--
--
355.36
556.55
Market Cap ($ Cr) info
10,487.71
--
--
--
--
--

Solvency Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Debt to Equity info
0.11
0.21
0.21
0.16
0.14
0.02
Short term debt to equity ratio info
0.06
0.01
0.01
0.00
0.00
0.00
Current Ratio info
3.18
5.62
6.48
5.83
5.55
2.92
Quick Ratio info
2.37
4.19
4.85
4.34
4.29
2.08
Interest Coverage info
28.05
21.32
-46.90
-16.20
-122.43
3,514.25

Operating Efficiency Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Debtors to sales (%) info
16.30
18.29
17.63
18.31
17.65
14.49
Asset Turnover info
0.24
0.26
0.24
0.21
0.18
0.19
Receivable days info
--
65.39
66.99
67.25
59.84
52.68
Inventory Days info
--
221.09
236.89
220.12
191.00
169.83
Payable days info
--
37.02
41.04
41.04
40.96
40.01
Cash Conversion Cycle info
--
249.46
262.84
246.33
209.88
182.50
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...